TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -1 | 4 | -1 | 12 | 14 | -59 | -5 |
| P | %wins | 0 | 100 | 0 | 100 | 100 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/9/08 14:07 | 1/7/08 | BPAX | Biosante Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kjaer Peter | NY | D | P.m | 55 | 3.63 | 1 | 15 | 77 | 34 | D | 4 | 29 | -40 | -37 | -21 | 2 | -7 | 1 | -1 | 4 | -1 | 12 | 14 | -59 | |
10/28/04 11:04 | 10/27/04 | BPA | Biosante Pharmaceuticals Inc | WY | Health | BioPrd | Biological Products, (No Diag | Kjaer Peter | NY | D | M.d | 21 | 2.85 | 0 | 8 | 63 | 19 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |